231 related articles for article (PubMed ID: 33363204)
21. Potential Prospective Biomarkers for Non-small Cell Lung Cancer: Mini-Chromosome Maintenance Proteins.
Huang C; Lei C; Pan B; Fang S; Chen Y; Cao W; Liu L
Front Genet; 2021; 12():587017. PubMed ID: 33936158
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive analysis of prognostic value and immune infiltration of kindlin family members in non-small cell lung cancer.
Su X; Liu N; Wu W; Zhu Z; Xu Y; He F; Chen X; Zeng Y
BMC Med Genomics; 2021 May; 14(1):119. PubMed ID: 33934696
[TBL] [Abstract][Full Text] [Related]
23. LncRNA FAM83A-AS1 promotes lung adenocarcinoma progression by enhancing the pre-mRNA stability of FAM83A.
Wang W; Zhao Z; Xu C; Li C; Ding C; Chen J; Chen T; Zhao J
Thorac Cancer; 2021 May; 12(10):1495-1502. PubMed ID: 33687144
[TBL] [Abstract][Full Text] [Related]
24. Expression profile and prognostic values of STAT family members in non-small cell lung cancer.
Yang M; Chen H; Zhou L; Chen K; Su F
Am J Transl Res; 2019; 11(8):4866-4880. PubMed ID: 31497205
[TBL] [Abstract][Full Text] [Related]
25. Expression signature, prognosis value and immune characteristics of cathepsin F in non-small cell lung cancer identified by bioinformatics assessment.
Song L; Wang X; Cheng W; Wu Y; Liu M; Liu R; Zhang S; Xia H; Liu H; Tai X; Zhao H; Li X; Ji F
BMC Pulm Med; 2021 Dec; 21(1):420. PubMed ID: 34923982
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive Analysis of Aquaporin Superfamily in Lung Adenocarcinoma.
Lin G; Chen L; Lin L; Lin H; Guo Z; Xu Y; Hu C; Fu J; Lin Q; Chen W; Zeng Y; Xu Y
Front Mol Biosci; 2021; 8():736367. PubMed ID: 34708074
[No Abstract] [Full Text] [Related]
27. Prognostic Value and Related Regulatory Networks of MRPL15 in Non-Small-Cell Lung Cancer.
Zeng Y; Shi Y; Xu L; Zeng Y; Cui X; Wang Y; Yang N; Zhou F; Zhou Y
Front Oncol; 2021; 11():656172. PubMed ID: 34026630
[TBL] [Abstract][Full Text] [Related]
28. FAM83A is amplified and promotes tumorigenicity in non-small cell lung cancer via ERK and PI3K/Akt/mTOR pathways.
Hu H; Wang F; Wang M; Liu Y; Wu H; Chen X; Lin Q
Int J Med Sci; 2020; 17(6):807-814. PubMed ID: 32218702
[TBL] [Abstract][Full Text] [Related]
29. FAM83A and FAM83A-AS1 both play oncogenic roles in lung adenocarcinoma.
Wang G; Li X; Yao Y; Jiang Z; Zhou H; Xie K; Luo J; Shen Y
Oncol Lett; 2021 Apr; 21(4):297. PubMed ID: 33732373
[TBL] [Abstract][Full Text] [Related]
30.
Yu J; Hou M; Pei T
DNA Cell Biol; 2020 May; 39(5):890-899. PubMed ID: 32282228
[TBL] [Abstract][Full Text] [Related]
31. FAM83A drives PD-L1 expression via ERK signaling and FAM83A/PD-L1 co-expression correlates with poor prognosis in lung adenocarcinoma.
Zhou F; Wang X; Liu F; Meng Q; Yu Y
Int J Clin Oncol; 2020 Sep; 25(9):1612-1623. PubMed ID: 32430734
[TBL] [Abstract][Full Text] [Related]
32. Systematic Analysis of the Expression and Prognosis of Fcγ Receptors in Clear Cell Renal Cell Carcinoma.
Nie W; Yao Y; Luo B; Zhu J; Li S; Yang X; Luo T; Liu W; Yan S
Front Oncol; 2022; 12():755936. PubMed ID: 35372055
[TBL] [Abstract][Full Text] [Related]
33. LncRNA FAM83A-AS1 facilitates tumor proliferation and the migration via the HIF-1α/ glycolysis axis in lung adenocarcinoma.
Chen Z; Hu Z; Sui Q; Huang Y; Zhao M; Li M; Liang J; Lu T; Zhan C; Lin Z; Sun F; Wang Q; Tan L
Int J Biol Sci; 2022; 18(2):522-535. PubMed ID: 35002507
[No Abstract] [Full Text] [Related]
34. SNRPD1/E/F/G Serve as Potential Prognostic Biomarkers in Lung Adenocarcinoma.
Liu G; Li F; Chen M; Luo Y; Dai Y; Hou P
Front Genet; 2022; 13():813285. PubMed ID: 35356432
[No Abstract] [Full Text] [Related]
35. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
[TBL] [Abstract][Full Text] [Related]
36. Pan-cancer analysis of the FAM83 family and its association with prognosis and tumor microenvironment.
Yuan S; Huang Z; Qian X; Wang Y; Fang C; Chen R; Zhang X; Xiao Z; Wang Q; Yu B; Li Y
Front Genet; 2022; 13():919559. PubMed ID: 35938024
[TBL] [Abstract][Full Text] [Related]
37. Mining expression and prognosis of topoisomerase isoforms in non-small-cell lung cancer by using Oncomine and Kaplan-Meier plotter.
Hou GX; Liu P; Yang J; Wen S
PLoS One; 2017; 12(3):e0174515. PubMed ID: 28355294
[TBL] [Abstract][Full Text] [Related]
38. Long noncoding antisense RNA FAM83A-AS1 promotes lung cancer cell progression by increasing FAM83A.
Shi R; Jiao Z; Yu A; Wang T
J Cell Biochem; 2019 Jun; 120(6):10505-10512. PubMed ID: 30659636
[TBL] [Abstract][Full Text] [Related]
39. Expression of Mucin Family Proteins in Non-Small-Cell Lung Cancer and its Role in Evaluation of Prognosis.
Tu J; Tang M; Li G; Chen L; Wang Y; Huang Y
J Oncol; 2022; 2022():4181658. PubMed ID: 36059804
[TBL] [Abstract][Full Text] [Related]
40.
Zhang XZ; Chen MJ; Fan PM; Jiang W; Liang SX
Int J Gen Med; 2022; 15():2727-2745. PubMed ID: 35300128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
